Protective effect of panaxydol against repeated administration of aristolochic acid on renal function and lipid peroxidation products via activating Keap1‐Nrf2/ARE pathway in rat kidney
- 7 September 2020
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 35 (1) , e22619
Abstract
Panaxydol (PX), a polyacetylenic compound isolated from the roots of Panax notoginseng, is found to possess various biological functions. However, its protective effects against aristolochic acid (AA)‐induced renal injury have not been elucidated yet. The present study was undertaken to elucidate the renoprotective effect of PX on Wistar male rats via activating Keap1‐Nrf2/ARE pathway. Experimental animals were randomized into four groups, such as control group, I/R group, AA (5 mg/kg/d; ip for 10 days), and AA‐induced rats treated with PX (10 and 20 mg/kg/d; po for 20 days). At the end of the experimental period, the rats were killed, and the biochemical parameters denoting renal functions were evaluated; histological analysis displaying the renal tissue architecture, real‐time quantitative reverse‐transcription polymerase chain reaction, and immunohistochemistry (IHC) analysis of Keap1‐Nrf2/ARE genes were elucidated. The results demonstrated that the rats administered with AA displayed a significant increase in the blood urea nitrogen level with an increased urine creatinine and protein excretion. Also, the serum levels of urea, uric acid, and albumin levels were increased. Furthermore, the histological evaluation denoted the cellular degeneration with increased tissue lipid peroxidation levels. In contrast, rats administered with PX significantly prevented the tissue degeneration with improved antioxidant levels. Conversely, PX treatment increased the messenger RNA expression of Nrf2, NQO1, HO‐1 with an attenuated expression of 4HNE and NOX‐4 levels in IHC analysis. Thus, the results of the present study suggest that PX could suppress AA‐induced renal failure by suppressing oxidative stress through the activation of Keap1‐Nrf2 signaling pathway.Keywords
This publication has 39 references indexed in Scilit:
- Biosynthesis of Panaxynol and Panaxydol in Panax ginsengMolecules, 2013
- Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad SignalingPLOS ONE, 2012
- Nrf2 Activators as Attractive Therapeutics for Diabetic NephropathyDiabetes, 2011
- Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis miceFree Radical Biology and Medicine, 2011
- Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2011
- Chemical and Pharmacological Studies of Saponins with a Focus on American GinsengJournal of Ginseng Research, 2010
- Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2Chemico-Biological Interactions, 2009
- Compositional and Oxidative Analysis in the Saliva and Serum of Predialysis Chronic Kidney Disease Patients and End‐stage Renal Failure Patients on Peritoneal DialysisTherapeutic Apheresis and Dialysis, 2008
- Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic ReviewPLOS Medicine, 2007
- Protective effect of panaxydol and panaxynol on sodium nitroprusside-induced apoptosis in cortical neuronsChemico-Biological Interactions, 2006